What question did this study set out to answer?

The aim is to explore the applications of next-generation sequencing in liquid biopsy for cancer screening and early detection.

August 1, 2019Human GenomicsOpen Access

Next-generation sequencing in liquid biopsy: cancer screening and early detection

View Full Paper

Ask AI

Bookmark

Authors

Reviews applications of liquid biopsy for early cancer screening, implying significant implications for diagnosis and treatment.

The aim is to explore the applications of next-generation sequencing in liquid biopsy for cancer screening and early detection.
Review of NGS technologies and ctDNA sequencing methods
Analysis of the challenges in implementing liquid biopsy for population screening
Summary of recent advancements and future research directions in cancer applications.
Liquid biopsy allows non-invasive monitoring of cancer across all stages.
Early detection through ctDNA sequencing can improve survival rates and reduce disease burden.
Implementation in population screening poses significant challenges despite high sensitivity of ctDNA methods.

Chen et al. (2019) studied this question.

View Full Paper

Ask AI

Bookmark